Results 171 to 180 of about 49,135 (301)

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

Circulation, 2015
D. Graham, M. Reichman, M. Wernecke, Rongmei Zhang, M. Southworth, Mark S Levenson, T. Sheu, Katrina Mott, M. Goulding, Monika Houstoun, T. MaCurdy, C. Worrall, J. Kelman   +12 more
semanticscholar   +1 more source

Lack of an antagonist to reverse the action of dabigatran [PDF]

, 2011
Oscar M.P. Jolobe
openalex   +1 more source

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects

Circulation, 2011
E. Eerenberg, P. Kamphuisen, M. Sijpkens, J. Meijers, H. Buller, M. Levi   +5 more
semanticscholar   +1 more source

Comparing the Efficacy and Safety of Different DOACs (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) for Stroke Prevention in Atrial Fibrillation [PDF]

Dinesh Balamurugan, Collins Gilbert, Michael A�mann, Harsh Bansal   +3 more
openalex   +1 more source

Supratherapeutic dabigatran: a cause of life‐threatening haemorrhage*

, 2023
Mairead M. Hennessy, B. Reidy, Fionnuala Ní Áinle, John B. Conneely, Cian McDermott, P. Ó. Scanaill   +5 more
openalex   +2 more sources

Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI). [PDF]

BMC Med
Liang M, Jin J, Zhao R, Li H, Chen S, Liu L, Xu P, Wang W, Cheng X, Chen X, Tao L, Zhang Q, Yang M, Zeng C, Li L, Zheng Y, Chen H, Guo J, Zhong Z, Bi Y, Cheng B, Zhou Y, Wang H, Zhang Y, Qiu M, Zhang Q, Zhang P, Zhang J, Wang Z, Li Y, Han Y.   +30 more
europepmc   +1 more source

A Phase 1 Study to Assess the Effect of Fruquintinib on the Pharmacokinetics of P-gp and BCRP Substrates in Healthy Subjects. [PDF]

Clin Transl Sci
Gonzalez M, Yang Z, Schelman WR, Zhou X, Gupta N, Chien C.   +5 more
europepmc   +1 more source

Cardiovascular and biochemical studies on the effects of thrombin and dabigatran and the interaction with vasopressor molecules

, 2014
R. Anand, Karupannan Arumugasamy, Manoj Tyagi   +2 more
openalex   +2 more sources

Conservative Management of Intentional Massive Dabigatran Overdose [PDF]

, 2015
Nicola Mumoli, Marco Cei, Marcello Fiorini, Paolo Pennati, Sophie Testa, Francesco Dentali   +5 more
openalex   +1 more source

The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis. [PDF]

Hum Genomics
Aldiban W, Hamam NG, Almosilhy NA, Elsamman K, Wagdy M, Mashaly D, Batarseh SF, El-Sherif Y, Khalefa BB, Otmani Z.   +9 more
europepmc   +1 more source